Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study of the Pharmacological Reversal of the Residual Neuromuscular Blockade in Bariatric Surgery

NCT04244266 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.

NCT NCT04244266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04244266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study of the Pharmacological Reversal of the Residual Neuromuscular Blockade in Bariatric Surgery
Lead sponsor
Poitiers University Hospital
Phase
Observational
Overall status
Completed
Start date
January 29, 2020
Completion date
June 14, 2023
Enrollment
140 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neostigmine, obesity, residual neuromuscular blockade